EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Clinical Lung Cancer

ISSN 1525-7304 · Elsevier BV

Latest articles

  1. Modified CARG Score-Guided First-Line Treatment in Older or Vulnerable Patients With Advanced Non-Small-Cell Lung Cancer: Results of the Randomized, Phase 2 DURATION Trial (AIO-YMO/TRK-0416)

    Jonas Kuon, Miriam Blasi, FFarastuk Bozorgmehr, Konrad Kokowski, Martin Faehling, Philipp Schütt, Daniel Christoph Christoph, Martin Kimmich, Eva Lotte Buchmeier, Anke Reinacher-Schick, Matthias Ulmer, Christian Meyer zum Büschenfelde, Nicolas Moosmann, Frank Griesinger, Wolfang Schütte, Ludwig Fischer von Weikersthal, Bernd Schmidt, Wolfgang Gleiber, Heinz Kirchen, Martin Wermke, Paul La Rosé, Gerlinde Schmidtke-Schrezenmeier, Jean-Charles Moulin, Michael Boesche, Christian Grohé, Helga Bernhard, Dominik Modest, Christoph Maintz, Marc Alexander Schneider, Rouven Behnisch, Albrecht Stenzinger, Petros Christopoulos, Michael Thomas

    Published: 2026-12DOI: 10.1016/j.cllc.2026.10.004

  2. Detection of Actionable Genomic Alterations beyond EGFR, ALK and ROS1 in Non-Small Cell Lung Carcinoma: A Real-World Evaluation of a Pathology-Led Staggered Reflex Predictive Biomarker Testing Strategy in a Resource-Limited Setting

    Aruna Nambirajan, Kaustar Yadav, Saumya Sahu, Snehvarsha Bhagat, Prajna Gopalakrishna, Shraddanjali Satapathy, Warisa Khatoon, Suyash Devgan, Amita Singh, Aparna Sharma, Anant Mohan, Prabhat Singh Malik, Chitra Sarkar, Deepali Jain

    Published: 2026-12DOI: 10.1016/j.cllc.2026.10.006

  3. Osimertinib Plus Platinum-based Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Post-progression on First-Line Osimertinib: ORCHARD

    Jonathan W. Goldman, Jonathan W. Riess, Byoung Chul Cho, Sarah B. Goldberg, Xiuning Le, Zofia Piotrowska, Isamu Okamoto, Helena A. Yu, Rosario García-Campelo, Javier de Castro Carpeño, Simon Ekman, Noemi Reguart, Marthe S. Paats, Sang-We Kim, Yu Jung Kim, Makoto Nishio, Kristen A. Marrone, Knut B. Smeland, Lizza E.L. Hendriks, Hiroaki Akamatsu, Junichi Shimizu, Paul E. Smith, Kwan Ho Tang, Jonathan M. Lehman, Adrianus J. de Langen

    Published: 2026-11DOI: 10.1016/j.cllc.2026.09.001

  4. A Randomized Phase III Trial of Concurrent Chemoradiotherapy Followed by Durvalumab Consolidation, With or Without Induction Chemo-Immunotherapy, in Patients With Unresectable Locally Advanced Non–Small Cell Lung Cancer: JCOG2510 (PRIME-CRT)

    Kota Kawabata, Ken Masuda, Keita Miura, Yu Saida, Ryo Ko, Hiroaki Akamatsu, Hidehito Horinouchi, Takahito Chiba, Kae Okuma, Hideyuki Harada, Yoshimasa Shiraishi, Yasushi Goto, Shogo Nomura, Noriko Mitome, Haruhiko Fukuda, Isamu Okamoto, Hirotsugu Kenmotsu

    Published: 2026-11DOI: 10.1016/j.cllc.2026.09.007

  5. SAARC Consensus Recommendations for the diagnosis and treatment of non-small-cell lung cancer (NSCLC)

    Kumar Prabhash, Vanita Noronha, Srikant Anne, Ullas Batra, Sneha Bothra, M V Chandrakanth, Qamruzzaman Chowdhary, Arunangshu Das, Adnan Jabbar, Nadarajah Jeyakumaran, AFM Kamaluddin, Akhil Kapoor, Khalid Ahmad Khalid, Sewanti Limaye, Prabhat Malik, Nandini Menon, Bal Krishna Mishra, Goutam Panda, Vijay Patil, K Pavithran, Prabhat Pradhan, Arifur Rahman, Yasmin Abdul Rashid, Wasantha Rathnayake, T P Sahoo, Simit Sapkota, Minit Shah, Ramila Shilpakar, Mostafa Aziz Sumon, Birendra Yadav, Nauman Zahir, Ahmad Javid Zarang

    Published: 2026-11DOI: 10.1016/j.cllc.2026.11.003

  6. Outcomes and Treatment Patterns for Recurrence Following Concurrent Chemoradiation and Consolidation Durvalumab in Locally Advanced, Unresectable NSCLC: A Multi-Center Study

    Richard D. Hall, Philip Young, John Sharp, Kenan Michaels, Kylie Fultineer, James M. Larner, Marie C. Thomas, Alia C. Lynch, Mu-Hsun Chen, Hong Zhu, Mingjia Li, Logan Roof, Kai He, Peter Shields, Jacob Kaufman, Regan Memmott, Asrar Alahmadi, David P. Carbone, Gregory A. Otterson, Carolyn J. Presley, Karl Haglund, Jeremy Brownstein, Dwight H. Owen, Ryan D. Gentzler

    Published: 2026-11DOI: 10.1016/j.cllc.2026.11.006

Volumes

2026 · 1772025 · 2092024 · 1712023 · 1522022 · 1802021 · 2152020 · 1782019 · 1642018 · 1972017 · 1672016 · 1182015 · 1082014 · 842013 · 1132012 · 842011 · 692010 · 632009 · 972008 · 1012007 · 742006 · 762005 · 762004 · 682003 · 672002 · 632001 · 542000 · 631999 · 31

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.